Fig. 7: Schematic illustration of the study.

PEC’s anti-cancer mechanisms against BLCA involve targeting TOP2A to induce DNA damage, G2/M phase cell cycle arrest, and inhibition of the late autophagic flux.

PEC’s anti-cancer mechanisms against BLCA involve targeting TOP2A to induce DNA damage, G2/M phase cell cycle arrest, and inhibition of the late autophagic flux.